STEMCELL Technologies and Immudex have announced the launch of a new protocol that combines the power of the EasySep Release positive selection platform with Immudex's Dextramer® reagents, enabling ...
Of the 11 patients treated with BE-CAR7 T cells, seven are in remission, including one patient who has been in remission for three years.
In November, The Lancet published an international expert consensus review, "Contemporary, non-invasive imaging diagnosis of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback